The success of copyright’s blockbuster initially sparked a surge for the drug industry, but recent shifts present a uncertain picture for shareholders. Off-patent alternatives are eating into earnings, and persistent https://agneszusw061491.worldblogged.com/47556468/the-blue-pill-and-pharma-a-risky-investment